Page last updated: 2024-09-04

febuxostat and dapagliflozin

febuxostat has been researched along with dapagliflozin in 1 studies

Compound Research Comparison

Studies
(febuxostat)
Trials
(febuxostat)
Recent Studies (post-2010)
(febuxostat)
Studies
(dapagliflozin)
Trials
(dapagliflozin)
Recent Studies (post-2010) (dapagliflozin)
8181337101,4783681,407

Protein Interaction Comparison

ProteinTaxonomyfebuxostat (IC50)dapagliflozin (IC50)
Sodium/glucose cotransporter 1Homo sapiens (human)1.1661
Sodium/glucose cotransporter 2Homo sapiens (human)0.0022
Sodium/myo-inositol cotransporter 2Homo sapiens (human)0.38
Solute carrier family 5 member 4Homo sapiens (human)0.0014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dronamraju, N; Erlandsson, F; Goldwater, R; Han, D; Johansson, S; Johnsson, E; Oscarsson, J; Parkinson, J; Stack, AG1

Trials

1 trial(s) available for febuxostat and dapagliflozin

ArticleYear
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.
    The Journal of clinical endocrinology and metabolism, 2021, 04-23, Volume: 106, Issue:5

    Topics: Adult; Benzhydryl Compounds; Cross-Over Studies; Drug Therapy, Combination; Enzyme Inhibitors; Febuxostat; Female; Glucosides; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Naphthalenes; Propionates; Pyridines; Treatment Outcome; United States; Uric Acid; Uricosuric Agents; Young Adult

2021